Ketazolam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. Ketazolam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. It is grouped under the following drug class(es): Anxiolytics, Benzodiazepines and Schedule IV controlled substances. Its therapeutic use is listed as antianxiety drugs and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Unakalm, Ansieten and Loftran. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 33746.
Ketazolam
| CAS No | 27223-35-4 |
|---|---|
| Molecular Formula | C20H17ClN2O3 |
| Molecular Weight | 368.80 g/mol |
| Synonyms | 11-chloro-2,8-dimethyl-12b-phenyl-6H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ketazolam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. Ketazolam is a DEA Schedule IV controlled substance.
The listed CAS number is 27223-35-4.
The listed molecular formula is C20H17ClN2O3.
The listed molecular weight is 368.80 g/mol.
11-chloro-2,8-dimethyl-12b-phenyl-6H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-dione.
The source lists Unakalm, Ansieten and Loftran.